Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Xa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06382584
What this trial is testing

Impact of Treatment With Oral Anticoagulants of Patients With Fractures of the Upper End of the Femur

Who this might be right for
Direct Oral Anticoagulants (DOACs)Femoral FracturesSurgery
Centre Hospitalier Universitaire de Nīmes 610
Early research (Phase 1)Study completedNCT00629733
What this trial is testing

Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of a New Ultra Low Molecular Weight Heparin (RO-14) Administered Subcutaneously Increasing Single-doses to Healthy Male Volunteers

Who this might be right for
Healthy
Rovi Pharmaceuticals Laboratories 12
Not applicableWithdrawnNCT05554055
What this trial is testing

Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)

Who this might be right for
Aortic DiseasesArterial DiseaseThrombosis
Hospices Civils de Lyon
Not applicableLooking for participantsNCT06575309
What this trial is testing

THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin

Who this might be right for
Pregnant WomenVenous Thromboembolic Disease
University Hospital, Clermont-Ferrand 50
Not applicableStudy completedNCT00629447
What this trial is testing

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Who this might be right for
Primary Brain Tumor
Duke University 40
Large-scale testing (Phase 3)Ended earlyNCT04558892
What this trial is testing

Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.

Who this might be right for
Nephrotic Syndrome
Military Institute od Medicine National Research Institute 65
Large-scale testing (Phase 3)Study completedNCT00951574
What this trial is testing

Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)

Who this might be right for
Advanced CancerMetastatic Cancer
Italfarmaco 1,166
Testing effectiveness (Phase 2)Ended earlyNCT03297359
What this trial is testing

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Who this might be right for
CancerVenous ThromboembolismObesity
Ottawa Hospital Research Institute 92
Not applicableLooking for participantsNCT07302620
What this trial is testing

HEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENT

Who this might be right for
Thromboembolic Disease
University Hospital, Strasbourg, France 70
Large-scale testing (Phase 3)Study completedNCT00225108
What this trial is testing

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

Who this might be right for
Deep Vein Thrombosis
Ottawa Hospital Research Institute 30
Not applicableUnknownNCT01029821
What this trial is testing

Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis

Who this might be right for
Deep Venous Thrombosis
University of Tennessee 100
Not applicableStudy completedNCT03218514
What this trial is testing

Venous Thromboprophylaxis in Bariatric Surgery

Who this might be right for
Obesity
Groupe Hospitalier Pitie-Salpetriere 118
Not applicableStudy completedNCT01721928
What this trial is testing

Norwegian Intensive Care Unit Dalteparin Effect Study

Who this might be right for
Acute Kidney InjuryDeep Venous Thrombosis
Oslo University Hospital 70
Post-approval studies (Phase 4)Study completedNCT00965328
What this trial is testing

Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration

Who this might be right for
KidneyAcute Renal FailureMultiple Organ Failure
Onze Lieve Vrouwe Gasthuis 14
Large-scale testing (Phase 3)Study completedNCT02073682
What this trial is testing

Cancer Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+1 more
Daiichi Sankyo 1,046
Post-approval studies (Phase 4)Study completedNCT00203580
What this trial is testing

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Who this might be right for
ThrombosisThromboembolismVenous Thrombosis
University of Calgary 910
Not applicableUnknownNCT05279391
What this trial is testing

Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19

Who this might be right for
COVID-19 Severe Respiratory Failure
Democritus University of Thrace 150
Large-scale testing (Phase 3)Study completedNCT04569279
What this trial is testing

Rivaroxaban vs. Warfarin in CVT Treatment

Who this might be right for
Cerebral Vein Thrombosis
Damascus University 71
Large-scale testing (Phase 3)Study completedNCT00312013
What this trial is testing

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 503
Not applicableStudy completedNCT01064596
What this trial is testing

Fondaparinux Population Pharmacokinetic to Morbid Obese Patients in Post-operatory Bariatric Surgery

Who this might be right for
Morbid ObesityObesitySurgery
Centre Hospitalier Universitaire de Saint Etienne 40
Next Page